SMERUD Medical Research Group

SMERUD Medical Research Group

Oslo, Norway· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

SMERUD Medical Research Group is a well-established, private, full-service CRO with over 33 years of collective experience and a track record of more than 900 clinical trials across 75+ therapeutic areas. It offers end-to-end clinical development services including Clinical Operations, Regulatory Affairs, Data Management, Biostatistics, Pharmacovigilance, and Medical Writing, primarily serving clients in Northern Europe. The company's strength lies in its local presence across seven European countries, a highly educated and senior staff, and a strong commitment to quality and business ethics under its 'Semper excelsior' vision.

OncologyDermatologyCardiovascularRheumatologyPsychiatryVaccinationLung diseasesRare disordersUrologyGastroenterologyGynaecologyNeurologyChronic kidney disease

Technology Platform

Integrated full-service CRO platform (SMERUD SYSTEM) governed by ICH-GCP compliant SOPs. Capabilities include Clinical Operations, Regulatory Affairs, Data Management, Biostatistics, Pharmacovigilance (with QP services), and Medical Writing, delivered by senior, scientifically trained staff.

Opportunities

Growth in clinical trial outsourcing, especially in Northern and Eastern Europe, and increasing complexity of trials in oncology and rare diseases.
Demand for mid-sized, expert CROs with senior staff and personalized service presents a key market niche.

Risk Factors

High competition from global and regional CROs, dependency on client R&D spending cycles, and operational risks related to regulatory compliance and project execution.
Geographic concentration in Europe also presents a regional market risk.

Competitive Landscape

Competes in the crowded global CRO market against large players (e.g., IQVIA, ICON) and other regional European CROs. Differentiates through senior-level expertise, a strong Northern European footprint, and a focus on quality and personalized service for biotech and pharma sponsors.